Stockscreener 앱 받기
23.05
4.87%
1.07
시간 외 거래:
23.02
-0.03
-0.13%
전일 마감가:
$21.98
열려 있는:
$21.78
하루 거래량:
259.52K
Relative Volume:
2.46
시가총액:
$1.41B
수익:
-
순이익/손실:
$-143.59M
주가수익비율:
-8.1633
EPS:
-2.8236
순현금흐름:
$-119.47M
1주 성능:
+6.47%
1개월 성능:
+9.76%
6개월 성능:
+53.77%
1년 성능:
+20.68%
1일 변동 폭
$21.42
$23.48
1주일 범위
$21.41
$23.48
52주 변동 폭
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
PHVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
23.05 | 1.41B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 개시 | Guggenheim | Buy |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-09-25 | 개시 | Wedbush | Outperform |
| 2023-08-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | 개시 | Bryan Garnier | Buy |
| 2022-09-13 | 재개 | JMP Securities | Mkt Outperform |
| 2022-08-23 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-05-25 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-02 | 개시 | BofA Securities | Neutral |
| 2021-03-02 | 개시 | Morgan Stanley | Overweight |
| 2021-03-02 | 개시 | Oppenheimer | Outperform |
| 2021-03-02 | 개시 | SVB Leerink | Outperform |
모두보기
Pharvaris Nv 주식(PHVS)의 최신 뉴스
Is Pharvaris N.V. stock a good pick for beginnersIndex Update & Verified Momentum Stock Alerts - خودرو بانک
Published on: 2025-09-05 14:09:39 - Newser
Pharvaris N.V. shares rise 2.62% intraday after presenting at Wells Fargo 20th. - AInvest
Is Pharvaris N.V. still worth holding after the dipJuly 2025 Highlights & Entry Point Confirmation Signals - Newser
Can Pharvaris N.V. rally from current levels2025 Market Overview & Trade Opportunity Analysis Reports - Newser
Is Pharvaris N.V. stock showing strong momentum2025 Pullback Review & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Can swing trading help recover from Pharvaris N.V. losses2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Pharvaris N.V.'s Strategic Positioning in the 2025 Healthcare Innovation Landscape - AInvest
What institutional flow reveals about Pharvaris N.V.Portfolio Value Summary & Accurate Intraday Trade Tips - Newser
Pharvaris N.V.’s Strategic Positioning in the Biotech Sector: Capitalizing on Innovation Momentum - AInvest
Will Pharvaris N.V. see short term momentum2025 Volatility Report & AI Powered Buy/Sell Recommendations - Newser
Pharvaris N.V. (PHVS): A High-Potential Biotech Play in the Oral Angioedema Treatment Space - AInvest
Pharvaris N.V. Presents at Cantor Global Healthcare Conference 2025 - AInvest
Does Pharvaris N.V. outperform in volatile marketsJuly 2025 Price Swings & Precise Buy Zone Identification - خودرو بانک
Is Pharvaris N.V. stock poised for growthJuly 2025 Summary & Verified Technical Signals - Newser
Pharvaris N.V.'s Strategic Momentum in Bradykinin-Mediated Angioedema Therapeutics - AInvest
Pharvaris N.V. stock daily chart insightsJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
Evaluating Pharvaris N.V. with trendline analysis2025 Market Overview & Expert Curated Trade Ideas - Newser
Will Pharvaris N.V. stock recover after recent dropProfit Target & Daily Oversold Bounce Ideas - Newser
Applying Elliott Wave Theory to Pharvaris N.V.CEO Change & Safe Capital Preservation Plans - Newser
Measuring Pharvaris N.V.’s beta against major indicesWeekly Volume Report & Daily Price Action Insights - Newser
How to monitor Pharvaris N.V. with trend dashboardsWeekly Profit Report & Verified Stock Trade Ideas - Newser
What technical models suggest about Pharvaris N.V.’s comebackJuly 2025 Closing Moves & Technical Pattern Recognition Alerts - Newser
Published on: 2025-09-03 12:38:53 - Newser
Pharvaris N.V. stock outlook for YEARQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
Best data tools to analyze Pharvaris N.V. stockJuly 2025 Trade Ideas & Community Verified Trade Alerts - Newser
Analyzing Pharvaris N.V. with risk reward ratio chartsJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
What candlestick patterns are forming on Pharvaris N.V.2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - Newser
Pharvaris N.V. stock momentum explained2025 Market Sentiment & Short-Term High Return Ideas - Newser
How to use a screener to detect Pharvaris N.V. breakoutsJuly 2025 Review & Capital Efficiency Focused Strategies - Newser
Is Pharvaris N.V. benefiting from innovation trendsEarnings Growth Summary & AI Driven Stock Reports - خودرو بانک
Will Pharvaris N.V. outperform tech stocks2025 Price Momentum & Technical Pattern Recognition Alerts - خودرو بانک
Should you hold or exit Pharvaris N.V. nowDollar Strength & Growth Oriented Trade Recommendations - Newser
Can Pharvaris N.V. withstand a market correctionJuly 2025 Pullbacks & Free Daily Entry Point Trade Alerts - خودرو بانک
Will a bounce in Pharvaris N.V. offer an exitPortfolio Growth Summary & Smart Money Movement Tracker - Newser
Earnings visualization tools for Pharvaris N.V.Trade Volume Report & Growth Oriented Trade Recommendations - Newser
Applying sector rotation models to Pharvaris N.V.July 2025 Selloffs & Verified Entry Point Detection - Newser
Pharvaris Nv (PHVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):